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Abstract 
Background: Bipolar disorder is a chronic illness that impairs functioning and affects the quality of life of patients. 
The onset of this illness usually occurs at an early age, and the risk of relapse remains high for decades. Thus, due to 
the great clinical relevance of identifying long‑term predictors of functioning in bipolar disorder, Strauss and Carpen‑
ter developed a scale composed of items known to have prognostic value.
Methods:  To determine the clinical usefulness of the four‑item Strauss–Carpenter scale in bipolar disorder, a 1‑year 
prospective follow‑up study was carried out. The internal consistency, convergent and discriminant validity, and test–
retest reliability of the scale were assessed. We also compared the Strauss–Carpenter scale with the reference scales 
Global Assessment Functioning (GAF), Clinical Global Impression for Bipolar Disorder, the Modified Version (CGI‑BIP‑M) 
and the Sheehan Disability Scale (Sheehan). Additionally, a cut‑off point for remission was established.
Results: The total sample was composed of 98 patients with a diagnosis of bipolar disorder. The four‑item version of 
the Strauss–Carpenter scale showed to have appropriate psychometric properties, comparable to those of reference 
scales. The best cut‑off point for remission was 14.
Conclusions: The four‑item version of the Strauss–Carpenter scale has suitable validity and reliability for the assess‑
ment of functioning in patients with bipolar disorder.
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Background
Bipolar disorder is a chronic illness that affects function-
ing and the quality of life of patients both, during manic 
and depressive episodes and during remission (Rosa et al. 
2008; Burdick et  al. 2010; Jiménez et  al. 2012; Cotrena 
et  al. 2015). Patients show different clinical characteris-
tics, severity, comorbidities and treatment response. The 
prevalence of bipolar disorder I and II ranges from 2 to 
4 % (Kessler et al. 1994, 2005, 2012).
Since the onset of bipolar disorder usually occurs at 
an early age and the risk of relapse persists for decades 
until the age of 70 years (Angst et al. 2002), the identifi-
cation of long-term predictors of bipolar disorder risk is 
highly relevant to the clinical management and treatment 
of patients, as well as to the development of preventive 
strategies (Pinna and Manchia 2014).
In a longitudinal study, Strauss and Carpenter (1972) 
designed a four-item scale based on four areas of out-
come dysfunction which had been used as criteria of 
outcome in other studies. The authors demonstrated that 
this scale was effective in predicting outcomes in schizo-
phrenia with a follow-up of 2 years. Some decades later, 
Poirier et al. (2004) validated the French translation of a 
revised version of the latter scale in patients with schizo-
phrenia (SCOCS-R). The scale showed a high reliability 
and validity. Nieman et  al. (2013) analyzed an extended 
version of the Strauss–Carpenter scale (Strauss and 
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Carpenter 1974) and found that it was effective in pre-
dicting transition to a first psychotic episode in patients 
at high risk of psychosis. This scale has been used in 
many studies on first psychotic episodes that included 
patients diagnosed either with schizoaffective disorder 
or bipolar disorder (Melle et  al. 2000; Castro-Fornieles 
et al. 2011; Evensen et al. 2012; Barbeito et al. 2014; Jor-
dan et al. 2014; Parellada et al. 2015). However, although 
the scale has been translated into Spanish for its use in 
schizophrenia (Ahuir et al. 2009), it has not been trans-
lated yet for its use in bipolar disorder, despite that Span-
ish is the second-most spoken language in the world. The 
objective of this study was to assess the reliability and 
validity of the four-item Strauss–Carpenter prognostic 
scale in measuring functioning in patients with bipolar 
disorder in the Spanish population.
Methods
Design
A 1-year follow-up longitudinal study was performed 
to validate a brief version (four items) of the Strauss–
Carpenter scale for patients with bipolar disorder. The 
reliability, internal consistency, convergent and pre-
dictive validity, and prognostic capacity of the scale 
were assessed. To such purpose, the level of correlation 
between the score obtained on the four-item scale and 
two reference variables of functioning was evaluated.
Subjects
A total of 98 patients formed the final sample of the 
study. All subjects were aged between 18 and 65  years 
and met the diagnostic criteria for bipolar disorder type 
I as assessed by the Structured Clinical Interview for The 
Diagnostic for the Statistical Manual of Mental Disor-
ders, 4th edition (DSM-IV), Axis I Disorders (SCID-I) 
(American Psychiatric Association 1994). The study was 
carried out at Araba University Hospital, Vitoria, Spain. 
All patients were included after informed consent for 
participation was obtained. The exclusion criteria were: 
organic brain disorder, comorbidity with organic mental 
retardation or clinical decompensation requiring hospi-
talization in an acute inpatient unit.
Measures
The original scale was translated from English to Span-
ish by two independent bilingual translators who were 
familiar with the content and purposes of the scale. Each 
of them made a forward translation of the scale and then 
both translations were merged into the final version 
of the scale. Subjects were evaluated using a protocol 
that included the following scales: the Strauss–Carpen-
ter prognostic scale (Strauss and Carpenter 1972), was 
employed to assess the psychosocial functioning of 
patients. This scale consists of four items rated from 0 
to 4 on a Likert-type scale and yields a total score that is 
calculated by the addition of all item scores: the higher 
the score, the better is the prognosis; Global Assessment 
Functioning (GAF) (Endincott et  al. 1976), which also 
evaluates the general functioning of patients and in which 
a higher score indicates better functioning; the Clinical 
Global Impression for Bipolar Disorder, Modified Ver-
sion (CGI-BIP-M) (Vieta et al. 2002), which assesses the 
severity of the disease; and the Sheehan Disability Scale 
(Sheehan et  al. 1996), which assesses functional impair-
ment in patients. The interpretation of the two latter 
scales is inverse; therefore, higher scores indicate higher 
gravity. All subjects were evaluated using this protocol at 
baseline and at 1-year follow-up.
Other relevant clinical and socio-demographic vari-
ables were also collected, such as age, gender, civil sta-
tus, educational level, suicide attempts, substance use or 
number of hospitalizations and episodes in the last year.
The study was approved by the Ethics and Research 
Committee of the Araba University Hospital.
Statistical analysis
The internal consistency of the Strauss–Carpenter scale 
was examined by assessing the homogeneity of items 
using Cronbach’s alpha.
Convergent validity was calculated using Pearson’s cor-
relation coefficient between the total score on Strauss–
Carpenter scale and scores on the reference scales at 
baseline (GAF and Sheehan), as we considered they were 
continuous variables. The Spearman correlation was 
used to assess correlations with the CGI-BIP-M scale, as 
it has an ordinal measure. The predictive validity of the 
scale was assessed by calculating Spearman correlations 
between items of the Strauss–Carpenter scale (since 
they have an ordinal measure) and the reference scales 
at 1  year. In the case of the total score on the Strauss–
Carpenter scale, its relation with the GAF and Sheehan 
scales was assessed by Pearson correlations. Consistency 
between values and test–retest reliability of the Strauss–
Carpenter was evaluated by comparing baseline and 
1-year values by intra-class correlation coefficients (ICC).
Finally, ROC curves were used to evaluate the dis-
criminant capacity of the scale. The area under the 
curve (AUC) and cutoff point for remission were also 
determined.
All statistical analyses were performed using the IMB 
SPSS statistical software package versions 23 and R 3.1.2 
(R Core Team 2014).
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Results
Socio‑demographic data
Of the 98 patients included in the sample, men accounted 
for 66.3  % of the sample, and the mean age was 29.38 
(8.11) years. Most subjects were single (85.4 %) and had 
primary education (41.2 %); seven (7.5 %) had attempted 
suicide. Regarding substance use, 27.7  % used alco-




Cronbach’s alpha for the items of the Strauss–Carpenter 
scale was 0.677.
Convergent validity
Pearson correlation between the total score on Strauss–
Carpenter and the reference scales was significant and in 
the expected direction, both, for the CGI-BP-M and the 
Sheehan scale (p < 0.001) (Table 2).
Test–retest reliability
Test–retest reliability was calculated using ICC. The total 
score on Strauss–Carpenter was found to have a good 
intra-class correlation (Table 3).
Predictive validity
Table  4 shows the correlation between the Strauss–
Carpenter scale (both of each item separately and of 
the total score) and 1-year values on the reference 
scales. A significant correlation was found between the 
Social Activity item (Item 3) and the total score on the 
Strauss–Carpenter scale and the three reference scales. 
The strongest correlation was observed with the Shee-
han scale (rho  =  −0.50 and r  =  −0.57, respectively). 
The Hospitalization item (Item 1) and the Symptoms 
item (Item 4) showed to be significantly correlated with 
both CGI-BIP-M and Sheehan. Of note, the Hospitali-
zation item was more strongly correlated with the CGI-
BIP-M scale (rho = −0.37), whereas the Symptoms item 
was more significantly correlated with the Sheehan scale 
(rho  =  −0.48). Finally, a significant relationship was 
observed between the Work item (item 2) and GAF and 
Sheehan scale, but not with the CGI-BIP-M. Again, the 
strongest correlation was observed with the Sheehan 
scale (rho = −0.38) (Table 4).
Discriminant capacity
The discriminant capacity of the four items of the 
Strauss–Carpenter scale was assessed using ROC 
curves. The area under the curve (AUC) was 0.784 (95 % 
CI 0.695–0.874), which indicates a good discriminant 
capacity, as it is close to 1, the maximum value (Fig. 1). 
Moreover, the best correlation between sensitivity and 
specificity (70 and 64.2  %, respectively) was obtained 
using a cutoff point of 14 in the total score on the four-
item Strauss–Carpenter scale.
Discussion
Currently, most instruments for assessing functional 
impairment in patients with bipolar disorder are based 
on global measures. The global assessment functioning 
Table 1 Socio-demographic data at baseline (n = 98)
Variables Categories n (%), means (SD)
Gender Men 65 (66.3 %)
Women 33 (33.7 %)
Age 29.38 (8.11)
Civil status Single 82 (85.4 %)
Married 10 (10.4 %)
Other 4 (4.2 %)
Educational level Without studies 0 (0 %)
Primary education 40 (41.2 %)
Secondary education 32 (33 %)
University 25 (25.8 %)
Alcohol 13 (27.7 %)
Cannabis 47 (48 %)
Other drugs 28 (28.9 %)
Suicide attempts 7 (7.5 %)
Previous episodes 1.25 (0.59)
Previous hospitalizations 1.10 (0.42)
Table 2 Convergent validity of  the four-item Strauss–Car-
penter scale
a  Spearman’s correlation coefficient rho is shown for the CGI-BIP-M scale
Reference scales Strauss–Carpenter scale
Pearson’s r coefficient p value
GAF 0.087 0.339
CGI‑BIP‑M −0.668a <0.001
Sheehan Disability Scale −0.871 <0.001
Table 3 Reliability analysis
Strauss–Carpenter scale Intraclass correlation coefficient 
(ICC)
Coef p 95 % CI
Item 1. Hospitalization 0.424 0.004 0.140–0.614
Item 2. Work 0.648 <0.001 0.475–0.764
Item 3. Social activity 0.609 <0.001 0.546–0.796
Item 4. Symptoms 0.588 <0.001 0.384–0.724
Strauss–Carpenter total score 0.749 <0.001 0.626–0.832
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(GAF) (Endincott et al. 1976) is the most commonly used 
tool for the evaluation of functioning. Nevertheless, sev-
eral studies suggest that this scale might be mediated by 
symptoms (Samara et al. 2014; Suzuki et al. 2015).
There are few instruments that assess different areas of 
impairment and also have a prognostic value. The Func-
tioning Assessment Short Test (FAST) validated by Rosa 
et al. (2007) is divided into six specific areas of function-
ing: Autonomy, Occupational Functioning, Cognitive 
Functioning, Finances, Personal Relationships and Lei-
sure. This scale showed strong psychometric properties 
in the assessment of cognitive impairment in patients 
with bipolar disorder. Poirier et  al. (2004) validated the 
translation of a revised version of the Strauss–Carpen-
ter scale in schizophrenia. This version consisted of nine 
items and showed high reliability and validity. Ahuir et al. 
(2009) analyzed an extended version of the Strauss–Car-
penter scale (Strauss and Carpenter 1974) in schizophre-
nia and obtained high values of validity and reliability. 
This confirmed its good predictive properties. However, 
no reliable and valid instrument has been designed yet 
that assesses functioning and also has a prognostic value 
in bipolar disorder.
The results obtained in this study showed that the four-
item Strauss–Carpenter scale for patients with bipolar 
disorder have adequate psychometric characteristics for 
this population, both in terms of reliability and validity. 
Therefore, this is an adequate instrument with discrimi-
nant and prognostic capacity.
Regarding the internal consistency of the scale, 
although a psychometric instrument is generally consid-
ered reliable if Cronbach’s α  >  0.70 (Bland and Altman 
1997), in this study we have obtained a value of 0.677, 
which approaches this limit to be considered accept-
able. Besides, it must be considered that this coefficient is 
affected by the length of the scale (Streiner 2003).
With regard to convergent validity, we did not observe 
a significant correlation between the Strauss–Carpen-
ter and the GAF scale, although the CGI-BIP-M and the 
Sheehan scale were found to be strongly correlated. Fur-
ther, as expected, these correlations were inverse.
Ahuir et al. (2009) also demonstrated that the 17-item 
version of the Strauss–Carpenter scale has a high conver-
gent validity. In this case, the scale correlated significantly 
with the CGI, the World Health Organization Disability 
Assessment Schedule (WHO-DAS), the Positive And 
Negative Syndrome Scale (PANSS) and the Satisfaction 
With Life Domains Scale (SLDS), and also with the GAF.
Poirier et al. (2004) also obtained a high convergent valid-
ity although, in this case, correlation was with the Social 
and Occupational Functioning Assessment Scale (SOFAS).
In the analysis of the test–retest reliability, the items 
and total score on the Strauss–Carpenter scale showed 
adequate and high intra-class correlation coefficients 
(except for the hospitalization item). This confirms the 
stability and consistency of the first assessment of the 
test. The result for the Hospitalization item could be 
explained because one of the exclusion criteria was that 
Table 4 Correlations between Strauss and Carpenter and the reference scales
Italic values indicate the values reaching statistical significance (p < .05)
a  Pearson’s correlation coefficient r is shown for correlation between the total score of the Strauss–Carpenter and GAF and Sheehan scales
Strauss–Carpenter GAF CGI‑BIP‑M Sheehan p
rho p rho p rho
Item 1. Hospitalization 0.150 0.141 −0.365 0.012 −0.329 0.001
Item 2. Work 0.268 0.008 −0.155 0.127 −0.381 <0.001
Item 3. Social activity 0.254 0.012 −0.413 0.002 −0.500 <0.001
Item 4. Symptoms 0.189 0.063 −0.469 <0.001 −0.476 <0.001
Strauss–Carpenter total score 0.337a 0.001 −0.507 <0.001 −0.573a <0.001
Fig. 1 ROC curve of the four‑item Strauss–Carpenter scale
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patients were not hospitalized at recruitment, but they 
could have been hospitalized during follow-up. Thus, this 
item could have more variability in the test–retest.
Regarding the predictive validity of the four-item scale, 
the items with the best prognostic value were those 
that assess social activity and symptoms (Items 3 and 
4), which showed a high correlation with the reference 
scales. The total score on Strauss–Carpenter was also 
significantly related to the three reference scales, show-
ing a remarkably close relationship with the Sheehan 
scale (r = −0.573). As expected, this correlation supports 
the hypothesis on the predictive value of the scale. This 
agrees with the results published by Ahuir et  al. (2009), 
who observed a significant correlation (p < 0.01) between 
Strauss and Carpenter and GAF, CGI and WHO-DAS.
Finally, the ROC curves confirmed that the four-item 
Strauss–Carpenter scale has a high discriminant capac-
ity, with an area under the curve of 0.874. Moreover, we 
found that a cutoff point of 14 optimizes sensitivity (the 
probability that the test correctly detects subjects with a 
poor prognosis of functioning) and specificity (the prob-
ability that the test correctly detects subjects with a good 
prognosis of functioning).
This study has some limitations such as the small sam-
ple size and the short duration of follow-up (a year). 
Future studies should analyze the psychometric proper-
ties of the four-item Strauss–Carpenter scale in larger 
epidemiological samples and with a longer follow-up. 
Another limitation is that there was no control group in 
this study. Future studies should include a control group 
to confirm the results of this study.
Conclusions
The adaptation of the four-item Strauss–Carpenter scale 
to patients with bipolar disorder has adequate psycho-
metric properties and is an acceptable and very use-
ful instrument, not only for it shortness, but also for its 
prognostic capacity. This could have great clinical rel-
evance for the clinical and pharmacological management 
of patients. In addition, the use of this tool facilitates 
earl intervention to prevent the unfavorable evolution of 
patients with a worse  prognosis.
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